New Jersey Medical School
8
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 40/100
12.5%
1 terminated/withdrawn out of 8 trials
85.7%
-0.8% vs industry average
25%
2 trials in Phase 3/4
67%
4 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Kidney Disease After COVID-19
Role: collaborator
Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19
Role: collaborator
Therapeutic Epidural Patch Versus Pain Block in the Midface for Headache
Role: collaborator
Chronic Hypertension and Pregnancy (CHAP) Project
Role: collaborator
Strategy + RehaCom for Memory Rehabilitation in Traumatic Brain Injury (TBI)
Role: collaborator
PCORI-1502-27462 Navigating High Risk Surgery: Empowering Older Adults to Ask Questions That Inform Decisions About Surgical Treatment
Role: collaborator
Fructose Breath-testing in Irritable Bowel Syndrome (IBS)
Role: collaborator
Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT)
Role: collaborator
All 8 trials loaded